The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study

• Ngā kaituhi matua: Flora N. Balieva (Author), Andrew Y. Finlay (Author), Jörg Kupfer (Author), Lucía Tomas Aragones (Author), Lars Lien (Author), Uwe Gieler (Author), Françoise Poot (Author), Gregor B. E. Jemec (Author), Laurent Misery (Author), Lajos Kemeny (Author), Francesca Sampogna (Author), Henriët van Middendorp (Author), Jon Anders Halvorsen (Author), Thomas Ternowitz (Author), Jacek C. Szepietowski (Author), Nikolay Potekaev (Author), Servando E. Marron (Author), Ilknur K. Altunay (Author), Sam S. Salek (Author), Florence J. Dalgard (Author)
• Hōputu: Pukapuka
• I whakaputaina: Medical Journals Sweden, 2018-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Skin disease and its therapy affect health-related quality of life (HRQoL). The aim of this study was to measure the burden caused by dermatological therapy in 3,846 patients from 13 European countries. Adult outpatients completed questionnaires, including the Dermatology Life Quality Index (DLQI),...